You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. MyFAP: A Multimedia Intervention for Adolescents and Young Adults with FAP

    SBC: Radiant Creative Group, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): In this Phase II STTR application, we will build upon work conducted in our successful Phase I project which established the technical merit, acceptability and feasibility of developing a Web-based intervention, MyFAP.org, for adolescents and young adults (AYAs) with familial adenomatous polyposis (FAP). The main research goal of Phase II is to evaluate the eff ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Scaled and Optimized Internally Cooled Window

    SBC: MAINSTREAM ENGINEERING CORP            Topic: AF121092

    Forward-looking infrared seekers are the preferred guidance system for current and future hypersonic interceptors. Seeker performance is limited by the infrared window’s ability to survive and image in a high-Mach, endo-atmospheric environment where heating rates can exceed 80 W/cm². Window materials primarily fail because of thermal shock, but can also experience issues due to absorption/emiss ...

    STTR Phase II 2020 Department of DefenseMissile Defense Agency
  3. Urocortin Gene Transfer for CHF a Paracrine Approach Using Intravenous AAV

    SBC: Renova Therapeutics, Inc.            Topic: NHLBI

    DESCRIPTION provided by applicant Gene transfer for the treatment of cardiovascular diseases is bedeviled by inability to obtain safely and easily sufficient cardiac transgene expression Current methods of gene transfer for heart disease include intramuscular injection into heart muscle or intracoronary delivery approaches that are cumbersome to apply Consequently we have considered the u ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Optimized lactoferrin for treatment of intracerebral hemorrhage

    SBC: Pharmareview Corporation            Topic: 101

    DESCRIPTION provided by applicant Intracerebral hemorrhage ICH is a major public health problem with the highest mortality rate of all stroke subtypes ICH is one of the leading causes of long term disability Since there are no available FDA approved therapies for ICH it is of vast importance to search for new approaches in treatment for this devastating medical condition Lactoferrin LT ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Resilient Control Electronics

    SBC: IRIS TECHNOLOGY CORPORATION            Topic: MDA17T003

    As the orbital space around the earth gets more and more crowded with civilian and military reconnaissance, weather, tracking, communication, and navigation satellites - civilian and military users become increasingly dependent on the services provided by these spacecraft. This situation increases the possibility of offense actions against some or all of these spacecraft. The possibility calls for ...

    STTR Phase II 2020 Department of DefenseMissile Defense Agency
  6. Broad Spectrum Bitter Taste Antagonists Discovery

    SBC: DISCOVERYBIOMED, INC.            Topic: NIDCD

    Principal Investigators for Small Business: DiscoveryBioMed, Inc. (DBM) and Monell Chemical Senses Center Project Summary Abstract Bitter taste in foods and medicines presents a barrier to overcoming global public health challenges: food insecurity, poor nutritional health, and poor compliance with medication use, particularly among children and the elderly. Sugar and salt, the mainstays to addres ...

    STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  7. Comprehensive Surf Zone Modeling Tool

    SBC: ARETE ASSOCIATES            Topic: N19AT010

    The objective of this project is to advance the capabilities of the Coastal Battlefield Reconnaissance and Analysis (COBRA) system by creating a Surf Zone Modelling Tool (SZT) that can create realistic synthetic imagery of the surf zone (SZ). Through the use of this synthetic imagery the COBRA Program will be enabled to inform concept of operations (CONOPS) in unfamiliar environments as well as mo ...

    STTR Phase II 2020 Department of DefenseNavy
  8. Additively Manufactured Internally Cooled Window Frame

    SBC: MAINSTREAM ENGINEERING CORP            Topic: MDA18021

    Mounting of infrared (IR) windows on hypersonic vehicles is a critical design issue because of the stresses caused by high temperatures combined with the coefficient of thermal expansion (CTE) mismatch between the window and frame materials. Many applications use elastomeric seals to limit window distortion and stress by allowing for joint flexibility. However, windows and frames operating in this ...

    STTR Phase II 2020 Department of DefenseMissile Defense Agency
  9. BlueBox: A Complete Code Blue Data Recorder, Phase II

    SBC: NeoVative, Inc.            Topic: 400

    “Code blue” is the signal used in hospitals to call for an immediate cardiopulmonary resuscitation (CPR) following a cardiac or respiratory arrest. Reviewing the performance of the “code blue team” is a cornerstone for improving outcomes. The current standard of using handwritten records on a paper “code sheet” does not allow measurement of key quality indicators and is subject to huma ...

    STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Development of Spleen Tyrosine Kinase (SYK) negative allosteric modifiers for therapeutic intervention in Alzheimer's disease.

    SBC: ARCHER PHARMACEUTICALS, INC.            Topic: NIA

    Pathological hallmarks of Alzheimerandapos;s disease (AD) include extracellular deposits of Aβ peptides, intraneuronal aggregates of abnormally phosphorylated tau protein and neuroinflammation. Most proposed AD disease modifying therapies have focused on strategies that reduce brain Aβ/amyloid or tau pathological accumulation. However, such approaches have been unsuccessful in late stage AD clin ...

    STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government